A Behavioral Economics-Based Telehealth Intervention to Improve Post-MI Medication Adherence
Myocardial Infarction, Acute, Myocardial Infarction
About this trial
This is an interventional other trial for Myocardial Infarction, Acute focused on measuring Adherence, CleverCap® Lite BLE C035, Smartphone App, Telehealth, Digital Health, Mobile Phone App, Behavioral Economics, Aspirin, Wellth App
Eligibility Criteria
Inclusion Criteria:
- Over 21 years of age
- Admitted to one of the University of Pennsylvania hospitals for acute myocardial infarction (ICD-10 codes I21.xx) or unstable angina (ICD 10 codes I20.xxx)
- Prescribed once-per-day aspirin at discharge
- The patient administers his or her own medications
- Own a smartphone with a sufficient data plan or home Wi-Fi to enable app use and avoid overage charges
- Able to speak and understand English
Exclusion Criteria:
- Diagnosis of MI following non-cardiac admission
- Discharge to any facility other than the patient's home
- Cognitive impairment that limits ability to understand and complete questionnaires
- Inability to operate a mobile phone and the Wellth app
- Physician-estimated life expectancy less than 6 months
Sites / Locations
- University of Pennsylvania
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention Arm
Usual Care Control Arm
Participants receiving the Financial Incentive and Mobile Phone App will be given an smartphone app offering pill reminders and $50/month financial incentives for three months to upload photos of medication each day for 90 days. Medication adherence will be measured via a CleverCap(R) electronic monitoring pillbox.
Participants in the usual care control arm will receive the usual education about medications provided by hospital staff. Medication adherence will be measured via a CleverCap(R) electronic monitoring pillbox.